OTC heartburn use report
This article was originally published in The Tan Sheet
Consumers who use OTC heartburn medication saved on average $174 annually on physician visits and other medications, according to joint research from the Consumer Healthcare Products Association and the Nielsen Company. The report shows 94 percent of OTC heartburn users were satisfied with their treatment. The research, based on nearly 10,000 online consumer surveys conducted in 2008, also shows 61 percent surveyed said they did not discuss their symptoms with providers, according to a Jan. 26 release. The study included questions on antacids and proton pump inhibitors
You may also be interested in...
Novartis plans to prioritize converting patients currently treated with prescription Prevacid when the proton pump inhibitor becomes available over-the-counter, rather than winning over Prilosec OTC users, a Novartis executive said
Top executives at leading local and foreign drug firms in India by and large earned more in 2020-21, while differentials in CEO to median employee remuneration remained stark. With increasing scrutiny by shareholders and lawmakers, experts suggest that pharma should be more mindful of balancing “adequate” C-suite compensation and glaring inequalities.
Teva UK's first Rx-to-OTC switch is a UK Viagra Connect sildenafil competitor under the Liberize brand. Priced around 25% lower than the market leader, Teva's new brand must also compete with Perrigo's white label and Dr Reddy's Almus branded alternatives within the country's growing erectile dysfunction category.